9 completed. 4 Phase 1, 4 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 4 | Completed 4 |
| Phase 4 | 1 | Completed 1 |
Follow naftifine: new trials by email Literature Review of naftifine trials Research Report on naftifine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis UHE-103 Cream, Naftin (naftifine hydrochloride) Cream - Tinea Cruris, Tinea Pedis | Phase 1 | Completed | Therapeutics, Inc. | 42 | 2022-02-17 | 2024-04-10 |
| BE Study of Naftifine HCL Naftifine hydrochloride 2%, Placebo, Naftin® 2% (Naftifine hydrochloride 2%) - Tinea Pedis | Phase 3 | Completed | Genzum Life Sciences | 693 | 2015-03-01 | 2017-05-11 |
| Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis Naftifine Hydrochloride Gel 2%, Naftin® Gel 2%, Placebo Topical Gel - Tinea Pedis | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 1519 | 2014-06-27 | 2018-09-06 |
| Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis Naftifine Hydrochloride Cream 2%, Naftin® (Naftifine Hydrochloride) Cream 2%, Placebo Topical Cream - Tinea Pedis | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 890 | 2013-08-01 | 2017-05-09 |
| Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris Naftin 1% Cream, Placebo Cream - Tinea Cruris, Jock Itch | Phase 3 | Completed | Merz North America, Inc. | 65 | 2013-08-01 | 2015-04-15 |
| Pharmacokinetic Study of Pediatric Subjects With Tinea Cruris and Tinea Pedis NAFT500 (pediatric), NAFT600 (pediatric), NAFT500 (adult) - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Merz North America, Inc. | 56 | 2012-10-01 | 2016-07-14 |
| Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis Naftifine HCl Cream 1%, Naftin® (Naftifine HCl) Cream 1%, Placebo topical cream - Tinea Pedis | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 1053 | 2012-05-01 | 2014-05-06 |
| Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis NAFT-600 (naftin 2 % gel), Placebo - Tinea Pedis | Phase 3 | Completed | Merz North America, Inc. | 860 | 2011-02-01 | 2013-09-26 |
| Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis NAFT-600 ( naftin 2 % gel ), Placebo - Tinea Pedis | Phase 3 | Completed | Merz North America, Inc. | 855 | 2011-02-01 | 2013-09-26 |
Tinea Pedis (8) · Tinea Cruris (3) · Mycoses (2)
Merz North America, Inc. (4) · Sun Pharmaceutical Industries, Inc. (3) · Genzum Life Sciences (1) · Therapeutics, Inc. (1)
United States (5) · Dominican Republic (3) · Honduras (2) · Belize (1) · Puerto Rico (1)
Alan Fleischer, MD (1) · Lawrence Parish, MD (1) · Lawrency Parrish, MD (1) · Natalie Yantovskiy (1) · Stefan Plaum, MD (1) · Tony Andrasfay (1) · Zaidoon Al-Zubaidy (1)